Latest news with #AustralianVanadium
Business Insider
12-05-2025
- Business
- Business Insider
Analysts Offer Insights on Materials Companies: Australian Vanadium (OtherATVVF) and Northern Star Resources Ltd (OtherNESRF)
There's a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Australian Vanadium (ATVVF – Research Report) and Northern Star Resources Ltd (NESRF – Research Report) with bullish sentiments. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Australian Vanadium (ATVVF) In a report released today, Peter Kormendy from Shaw and Partners maintained a Buy rating on Australian Vanadium, with a price target of A$0.06. According to Kormendy is ranked #7581 out of 9504 analysts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Australian Vanadium with a $0.04 average price target. Northern Star Resources Ltd (NESRF) Northern Star Resources Ltd received a Buy rating and a A$22.50 price target from Citi analyst Kate McCutcheon today. The company's shares closed last Friday at $12.80. According to McCutcheon is a 4-star analyst with an average return of 8.4% and a 62.0% success rate. McCutcheon covers the Basic Materials sector, focusing on stocks such as Sandfire Resources Limited, Mineral Resources Limited, and Regis Resources Limited. Northern Star Resources Ltd has an analyst consensus of Moderate Buy, with a price target consensus of $14.47, which is a 14.7% upside from current levels. In a report issued on April 29, Goldman Sachs also maintained a Buy rating on the stock with a A$22.10 price target.
Business Insider
01-05-2025
- Business
- Business Insider
Shaw and Partners Sticks to Their Buy Rating for Australian Vanadium (ATVVF)
Shaw and Partners analyst Peter Kormendy maintained a Buy rating on Australian Vanadium (ATVVF – Research Report) today and set a price target of A$0.06. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Kormendy covers the Basic Materials sector, focusing on stocks such as Australian Vanadium , FireFly Metals, and AIC Mines Limited. According to TipRanks, Kormendy has an average return of -1.4% and a 36.14% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Australian Vanadium with a $0.04 average price target. The company has a one-year high of $0.02 and a one-year low of $0.00. Currently, Australian Vanadium has an average volume of 63.58K.
Yahoo
25-03-2025
- Business
- Yahoo
Bryah Resources exits government-funded partnership with Australian Vanadium
Australian miner Bryah Resources has withdrawn from a partnership agreement with Australian Vanadium formed to recover nickel, copper and cobalt from the tails stream of the Australian Vanadium project in Gabanintha, Australia. Australian Vanadium secured a government grant of up to A$49m to advance the project in May 2023. Bryah Resources was not entitled to the funding but had a liability of A$100,000, which has now been cleared. The company holds rights to all minerals except chromium, cobalt, iron ore, lithium, manganese, tantalum, titanium, uranium and vanadium over an 80km² project at Gabanintha, 40km south of Meekatharra, Western Australia (WA). Australian Vanadium retains full rights to these excluded minerals. Bryah Resources retains mineral rights for nickel, copper and gold at the project, which it is planning to sell due to growing interest in critical minerals. The company said in a statement: 'Given the interest in critical minerals and in-bound enquiries to Bryah, Bryah sees an opportunity to rationalise its asset base and dispose of the mineral rights and is actively marketing the sale. 'By monetising these mineral rights as soon as possible, it will free up funds to focus on other assets in the company. The tailings from the AVL project post mining relating to the mineral rights of Bryah could be processed later and treated independently.' In addition to base metals, Bryah Resources is also reviewing gold prospectivity in the Australian Vanadium project area. High-grade gold mineralisation has been identified within the mining lease, with significant gold intercepts from previous drilling. This includes a 10m intercept at 27.5 gram per tonne (g/t) of gold, highlighting the potential for significant gold mineralisation in cross-cutting fault zones. The indicated mineral resources portion of 16.1 million tonnes (mt) falls within the existing pit designs for Australian Vanadium's proposed 25-year vanadium project. This resource is expected to be processed through Australian Vanadium's 1.6mt per annum crushing, milling and beneficiation plant, which forms part of the 30.9mt high-grade vanadium resource included in the pits. In January 2025, the Australian Vanadium project, an integrated mining and processing development, received major project status from the WA Government for green energy. "Bryah Resources exits government-funded partnership with Australian Vanadium" was originally created and published by Mining Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
10-02-2025
- Business
- Yahoo
Australian Vanadium Leads The Charge Among 3 ASX Penny Stocks
The Australian market recently faced a slight downturn, with the ASX200 closing down 0.34% amid concerns over potential trade tensions sparked by President Trump's tariff threats. Despite these broader market uncertainties, penny stocks continue to attract attention for their potential to uncover hidden value in smaller or newer companies. Though the term 'penny stock' may seem outdated, it still signifies opportunities where strong financials and growth prospects can lead to significant returns. Name Share Price Market Cap Financial Health Rating Embark Early Education (ASX:EVO) A$0.79 A$141.28M ★★★★☆☆ LaserBond (ASX:LBL) A$0.595 A$66.88M ★★★★★★ EZZ Life Science Holdings (ASX:EZZ) A$1.895 A$89.63M ★★★★★★ Austin Engineering (ASX:ANG) A$0.485 A$306.97M ★★★★★☆ MaxiPARTS (ASX:MXI) A$1.88 A$106.21M ★★★★★★ Dusk Group (ASX:DSK) A$1.085 A$66.32M ★★★★★★ Helloworld Travel (ASX:HLO) A$2.03 A$332.15M ★★★★★★ SHAPE Australia (ASX:SHA) A$3.03 A$248.73M ★★★★★★ IVE Group (ASX:IGL) A$2.17 A$339.21M ★★★★☆☆ Vita Life Sciences (ASX:VLS) A$1.90 A$105.71M ★★★★★★ Click here to see the full list of 1,031 stocks from our ASX Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Australian Vanadium Limited, with a market cap of A$116.57 million, is involved in mineral exploration activities in Australia through its subsidiary. Operations: There are no revenue segments reported for this company. Market Cap: A$116.57M Australian Vanadium Limited, with a market cap of A$116.57 million, is a pre-revenue company involved in mineral exploration. It has stable short-term assets (A$37.7M) exceeding both its short-term (A$27.1M) and long-term liabilities (A$2.3M), ensuring a solid financial position despite being unprofitable and having increased losses over the past five years at 28.3% annually. The company benefits from an experienced management team but faces challenges with high volatility and limited cash runway if free cash flow continues to decline rapidly. Recent board changes include the resignation of Non-Executive Director Ms. Anna Sudlow due to external commitments. Click to explore a detailed breakdown of our findings in Australian Vanadium's financial health report. Gain insights into Australian Vanadium's future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Great Divide Mining Ltd is involved in the exploration and development of mineral resource properties in Australia, with a market capitalization of A$18.90 million. Operations: The company generates revenue from its Mineral Exploration and Resource Development segment, amounting to A$0.13 million. Market Cap: A$18.9M Great Divide Mining Ltd, with a market cap of A$18.90 million, is a pre-revenue entity focused on mineral exploration and development. Despite being debt-free and having short-term assets (A$1.6M) that cover both short-term (A$265.2K) and long-term liabilities (A$3.6K), it faces challenges such as less than one year of cash runway if current free cash flow trends persist, high share price volatility, and an inexperienced board with an average tenure of two years. The company recently held a special shareholders meeting to discuss potential changes under ASX Listing Rule 11.1.2 amidst ongoing unprofitability issues. Get an in-depth perspective on Great Divide Mining's performance by reading our balance sheet health report here. Learn about Great Divide Mining's historical performance here. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Optiscan Imaging Limited develops, manufactures, and commercializes endomicroscopic digital imaging technology for medical and pre-clinical applications across Australia, Germany, China, and the United States with a market cap of A$137.83 million. Operations: The company generates revenue from its Confocal Microscopes segment, amounting to A$2.99 million. Market Cap: A$137.83M Optiscan Imaging Limited, with a market cap of A$137.83 million, operates in the medical imaging sector but faces challenges as it remains unprofitable with earnings declining by 25.8% annually over the past five years. The company has limited revenue from its Confocal Microscopes segment (A$2.99 million) and a negative return on equity (-43.7%). Despite this, Optiscan has more cash than debt and short-term assets (A$15.1M) that exceed both short-term (A$1.8M) and long-term liabilities (A$7.9K). Recently, Ms. Elissa Hansen was appointed as Company Secretary to enhance corporate governance practices. Take a closer look at Optiscan Imaging's potential here in our financial health report. Review our historical performance report to gain insights into Optiscan Imaging's track record. Dive into all 1,031 of the ASX Penny Stocks we have identified here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:AVL ASX:GDM and ASX:OIL. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
10-02-2025
- Business
- Yahoo
Australian Vanadium Leads The Charge Among 3 ASX Penny Stocks
The Australian market recently faced a slight downturn, with the ASX200 closing down 0.34% amid concerns over potential trade tensions sparked by President Trump's tariff threats. Despite these broader market uncertainties, penny stocks continue to attract attention for their potential to uncover hidden value in smaller or newer companies. Though the term 'penny stock' may seem outdated, it still signifies opportunities where strong financials and growth prospects can lead to significant returns. Name Share Price Market Cap Financial Health Rating Embark Early Education (ASX:EVO) A$0.79 A$141.28M ★★★★☆☆ LaserBond (ASX:LBL) A$0.595 A$66.88M ★★★★★★ EZZ Life Science Holdings (ASX:EZZ) A$1.895 A$89.63M ★★★★★★ Austin Engineering (ASX:ANG) A$0.485 A$306.97M ★★★★★☆ MaxiPARTS (ASX:MXI) A$1.88 A$106.21M ★★★★★★ Dusk Group (ASX:DSK) A$1.085 A$66.32M ★★★★★★ Helloworld Travel (ASX:HLO) A$2.03 A$332.15M ★★★★★★ SHAPE Australia (ASX:SHA) A$3.03 A$248.73M ★★★★★★ IVE Group (ASX:IGL) A$2.17 A$339.21M ★★★★☆☆ Vita Life Sciences (ASX:VLS) A$1.90 A$105.71M ★★★★★★ Click here to see the full list of 1,031 stocks from our ASX Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Australian Vanadium Limited, with a market cap of A$116.57 million, is involved in mineral exploration activities in Australia through its subsidiary. Operations: There are no revenue segments reported for this company. Market Cap: A$116.57M Australian Vanadium Limited, with a market cap of A$116.57 million, is a pre-revenue company involved in mineral exploration. It has stable short-term assets (A$37.7M) exceeding both its short-term (A$27.1M) and long-term liabilities (A$2.3M), ensuring a solid financial position despite being unprofitable and having increased losses over the past five years at 28.3% annually. The company benefits from an experienced management team but faces challenges with high volatility and limited cash runway if free cash flow continues to decline rapidly. Recent board changes include the resignation of Non-Executive Director Ms. Anna Sudlow due to external commitments. Click to explore a detailed breakdown of our findings in Australian Vanadium's financial health report. Gain insights into Australian Vanadium's future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Great Divide Mining Ltd is involved in the exploration and development of mineral resource properties in Australia, with a market capitalization of A$18.90 million. Operations: The company generates revenue from its Mineral Exploration and Resource Development segment, amounting to A$0.13 million. Market Cap: A$18.9M Great Divide Mining Ltd, with a market cap of A$18.90 million, is a pre-revenue entity focused on mineral exploration and development. Despite being debt-free and having short-term assets (A$1.6M) that cover both short-term (A$265.2K) and long-term liabilities (A$3.6K), it faces challenges such as less than one year of cash runway if current free cash flow trends persist, high share price volatility, and an inexperienced board with an average tenure of two years. The company recently held a special shareholders meeting to discuss potential changes under ASX Listing Rule 11.1.2 amidst ongoing unprofitability issues. Get an in-depth perspective on Great Divide Mining's performance by reading our balance sheet health report here. Learn about Great Divide Mining's historical performance here. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Optiscan Imaging Limited develops, manufactures, and commercializes endomicroscopic digital imaging technology for medical and pre-clinical applications across Australia, Germany, China, and the United States with a market cap of A$137.83 million. Operations: The company generates revenue from its Confocal Microscopes segment, amounting to A$2.99 million. Market Cap: A$137.83M Optiscan Imaging Limited, with a market cap of A$137.83 million, operates in the medical imaging sector but faces challenges as it remains unprofitable with earnings declining by 25.8% annually over the past five years. The company has limited revenue from its Confocal Microscopes segment (A$2.99 million) and a negative return on equity (-43.7%). Despite this, Optiscan has more cash than debt and short-term assets (A$15.1M) that exceed both short-term (A$1.8M) and long-term liabilities (A$7.9K). Recently, Ms. Elissa Hansen was appointed as Company Secretary to enhance corporate governance practices. Take a closer look at Optiscan Imaging's potential here in our financial health report. Review our historical performance report to gain insights into Optiscan Imaging's track record. Dive into all 1,031 of the ASX Penny Stocks we have identified here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:AVL ASX:GDM and ASX:OIL. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
